Artelo Biosciences (ARTL) Other Working Capital Changes (2018 - 2025)
Artelo Biosciences (ARTL) posted quarterly Other Working Capital Changes of -$9000.0 for Q4 2025, down 12.5% year-over-year from -$10285.7 in Q4 2024, and little changed quarter-over-quarter from -$9000.0 in Q3 2025.
Artelo Biosciences (ARTL) Other Working Capital Changes (2018 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Other Working Capital Changes for 4 consecutive years, with -$9000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 12.5% year-over-year to -$9000.0; the TTM figure through Dec 2025 stood at -$35000.0 (down 16.67% YoY), while the FY2025 annual figure was -$35000.0, down 16.67% from the prior year.
- Other Working Capital Changes steadied at -$9000.0 in Q4 2025 per ARTL's latest filing, from -$9000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $594000.0 in Q1 2022 and bottomed at -$478000.0 in Q3 2024.
- Historically, Other Working Capital Changes has averaged -$48866.7 across 5 years, with a median of -$49000.0 in 2025.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 50.0% — and 2025, when it plunged 50.0%.
- Artelo Biosciences' Other Working Capital Changes stood at -$11000.0 in 2022, then climbed by 27.27% to -$8000.0 in 2023, then changed by 0.0% to -$8000.0 in 2024, then retreated by 12.5% to -$9000.0 in 2025.
- Business Quant data shows ARTL's Other Working Capital Changes at -$9000.0 in Q4 2025, -$9000.0 in Q3 2025, and -$9000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Sep 30, 2024 | -478,000.00 |
| Sep 30, 2024 | -478,000.00 |
| Sep 30, 2024 | -478,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |